Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$23.33 - $36.37 $1.08 Million - $1.68 Million
-46,310 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$29.34 - $35.0 $862,419 - $1.03 Million
29,394 Added 173.76%
46,310 $1.59 Million
Q2 2018

Aug 08, 2018

BUY
$27.33 - $41.46 $115,168 - $174,712
4,214 Added 33.18%
16,916 $546,000
Q1 2018

May 07, 2018

BUY
$20.21 - $32.0 $256,707 - $406,464
12,702 New
12,702 $367,000

Others Institutions Holding IFRX

About InflaRx N.V.


  • Ticker IFRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,203,800
  • Market Cap $99M
  • Description
  • InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...
More about IFRX
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.